Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Neoplasm Metastasis × X-Rays × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lymphoma, Non-Hodgkin 5 Wilms Tumor 4 Rhabdoid Tumor 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Neuroblastoma 4 Medulloblastoma 4 Histiocytosis, Langerhans-Cell 4 Hepatoblastoma 4 Glioma 4 Ependymoma 4 Sarcoma 3 Rhabdomyosarcoma 3 Osteosarcoma 3 Central Nervous System Neoplasms 3 Sarcoma, Ewing 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroendocrine Tumors 2 Malignant Solid Neoplasm 2 Lymphoma 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Thyroid Neoplasms 1 Thrombosis 1 Prostatic Neoplasms 1

Interventions

Gemcitabine 33 Paclitaxel 27 Capecitabine 27 pembrolizumab 26 Bevacizumab 26 Nivolumab 25 Fluorouracil 25 Docetaxel 24 Oxaliplatin 23 Cyclophosphamide 21 Leucovorin 20 Cisplatin 20 aldesleukin 17 Carboplatin 17 Radiosurgery 16 Irinotecan 15 Interleukin-2 15 fludarabine phosphate 14 fludarabine 14 Cetuximab 14 Prednisone 13 Ipilimumab 13 Trastuzumab 12 Pemetrexed 12 Fulvestrant 12 Everolimus 12 Magnetic Resonance Spectroscopy 11 Panitumumab 10 130-nm albumin-bound paclitaxel 10 abemaciclib 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03842228 2025-10-14

COD

National Cancer Institute (NCI)

Phase 1 Active not recruiting

39 enrolled 15 charts

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡